الفهرس 
METABOLIC SYNDROMEOnly 14 pages are availabe for public view
 |  | from | 173 |  |  |
| | | from | 173 | | |
Abstract
Metabolic syndrome (MS) and non-dipping hypertension both increase cardiovascular mortality. Although both clinical modalities share common pathophysiologic factors in their etiologies, previous studies did not find any association between them. (Tartan et al., 2006).
Metabolic syndrome is a complex disorder considered a ”multiplex” cardiovascular risk factor, in that each component of the cluster of abnormalities is a risk factor in its own right. Introduced as Syndrome X and also termed insulin resistance syndrome. (Haffner et al., 1998: Reaven, 1988). The metabolic syndrome has received increased attention in the past few years. It consists of multiple, interrelated risk factors of metabolic origin that appear to directly promote the development atherosclerotic cardiovascular disease. This constellation of metabolic risk factors is strongly associated with type 2 diabetes mellitus or the risk for this condition. The metabolic risk factors consist of atherogenic dyslipidemia (elevated triglycerides and low HDL cholesterol [HDL-C] concentrations), elevated blood pressure, and elevated plasma glucose. At present, it is not clear whether the metabolic syndrome has a single cause, and it appears that it can be precipitated by multiple underlying risk factors.